About
New Drugs and Clinical Trials Rules (India)
Course Introduction
About this course
The New Drugs and Clinical Trials Rules (NDCTR), 2019, notified under the Drugs and Cosmetics Act, represent a significant regulatory reform in India’s pharmaceutical and clinical research landscape. These rules aim to streamline the approval process for new drugs and clinical trials while ensuring the highest standards of safety, ethics, and scientific integrity. The NDCTR introduces provisions for accelerated approvals, ethical oversight, compensation mechanisms, and transparency in clinical research. It aligns India’s regulatory framework with global standards such as ICH-GCP, thereby promoting innovation, protecting trial participants, and facilitating faster access to new therapies.
The New Drugs and Clinical Trials Rules in India provide the contemporary regulatory framework governing how new medicines are studied, approved, and brought to market in the country — combining CDSCO oversight, ethics review, and patient-protection provisions into a coherent regulatory system.
This course builds foundational competence in the New Drugs and Clinical Trials Rules — covering the rules' structure, clinical trial approval pathways, ethics committee requirements, compensation provisions, and the regulatory pathway that determines drug development in India.
🎯 Built for clinical readiness. Concise, structured, and skill-focused — designed to translate directly into safer, more confident clinical practice.
Learning objectives
Course Objectives & Outcomes
What you will achieve
By the end of this course, learners will have built core clinical competencies directly applicable to everyday practice — translating into safer, more confident, more effective patient care.
Each outcome below targets a specific dimension of the New Drugs Rules — building the regulatory understanding required for confident Indian drug development practice.
By the end of this course, learners will be able to:
01
To ensure patient safety, rights, and well-being during clinical trials
02
To promote ethical and scientifically sound clinical research
03
To simplify and accelerate regulatory approvals for new drugs
04
To enhance transparency and accountability in clinical trial processes
05
To encourage innovation and research in India’s pharmaceutical sector
06
To harmonize Indian regulations with international guidelines (ICH-GCP)
07
To establish clear provisions for compensation, reporting, and monitoring
Cleaner regulation. Sharper compliance. Safer Indian drug development.
Build clinical confidence one skill at a time.
Who can enroll
Who Can Enroll
Built for these learners
This course is designed for healthcare learners and professionals seeking practical, skill-focused clinical training.
This course is built for pharmacy students, regulatory affairs professionals, clinical research staff, ethics committee members, and pharmaceutical industry professionals working with Indian regulations.
Designed for these learners
🧑⚕️
01
Pharmacy students (B.Pharm, M.Pharm, Pharm.D)
👨⚕️
02
Clinical research professionals and coordinators
👩⚕️
03
Medical graduates and healthcare practitioners
🦹
04
Regulatory affairs professionals
💊
05
Pharmaceutical industry professionals (R&D, QA, Clinical Operations)
🎓
06
Ethics Committee members and investigators
📝
07
Aspirants preparing for competitive exams (e.g., GPAT, NIPER, regulatory exams)
Sharper Skills. Stronger Practice.
Take the next step in your clinical journey with structured, skill-focused training.
Programme Certification
Your certificate
Upon successful completion of this programme, you will receive a digital certificate recognising your achievement and the competencies you have acquired throughout the course.
Certificates for TerraLeap programmes are issued and signed by authorised TerraLeap representatives. For programmes delivered in collaboration with universities, institutions, or industry organisations, certificates are jointly issued and co-signed by authorised representatives of both TerraLeap and the respective partner.
Each certificate carries a unique Certificate ID and QR code to enable instant authenticity verification — making it easy to share with employers, licensing bodies, or professional networks as evidence of your learning.
Note on scope. TerraLeap certificates confirm successful completion of the respective programme and recognise your professional development and continuing education. They do not constitute a professional licence or regulatory authorisation unless explicitly stated in the programme description.
TERRALEAP
Certificate ID
TL-2026-AB7K3X9P
Official
Seal
Certificate of Completion
Successfully Completed
Awarded in recognition of academic achievement
This is to certify that
XXXXX
has successfully completed the prescribed course of study, demonstrating commitment, diligence, and proficiency in
New Drugs and Clinical Trials Rules (India)
and is hereby awarded this certificate by TerraLeap, recognising the candidate's mastery of the syllabus and successful evaluation.